Tuberculosis treatment success rate in Chile
Chile: Tuberculosis treatment success rate was 69.0% in 2023. ▼ Falling
Tuberculosis treatment success rate in Chile, 1994–2023
Source: WHO (2025) – with minor processing by Our World in Data. Measured in %.
Analysis
The most recent figure for tuberculosis treatment success rate in Chile is 69.0%, measured in 2023.
The figure is down 2.8% on the previous year and up 46.8% over ten years.
Over the whole period, tuberculosis treatment success rate in Chile peaked at 86.0% in 2002 and was at its lowest, 44.0%, in 2012.
Chile ranks 164th of 206 countries on this measure, in the bottom quarter.
The long-run direction has been consistently falling across the 30 years of available data.
Tuberculosis treatment success rate in Chile, year by year
| Year | % | Change |
|---|---|---|
| 1994 | 83.0% | — |
| 1995 | 79.0% | -4.8% |
| 1996 | 80.0% | +1.3% |
| 1997 | 77.0% | -3.8% |
| 1998 | 83.0% | +7.8% |
| 1999 | 83.0% | +0.0% |
| 2000 | 82.0% | -1.2% |
| 2001 | 83.0% | +1.2% |
| 2002 | 86.0% | +3.6% |
| 2003 | 85.0% | -1.2% |
| 2004 | 83.0% | -2.4% |
| 2005 | 83.0% | +0.0% |
| 2006 | 85.0% | +2.4% |
| 2007 | 85.0% | +0.0% |
| 2008 | 72.0% | -15.3% |
| 2009 | 72.0% | +0.0% |
| 2010 | 71.0% | -1.4% |
| 2011 | 71.0% | +0.0% |
| 2012 | 44.0% | -38.0% |
| 2013 | 47.0% | +6.8% |
| 2014 | 58.0% | +23.4% |
| 2015 | 62.0% | +6.9% |
| 2016 | 79.0% | +27.4% |
| 2017 | 78.0% | -1.3% |
| 2018 | 73.0% | -6.4% |
| 2019 | 74.0% | +1.4% |
| 2020 | 77.0% | +4.1% |
| 2021 | 74.0% | -3.9% |
| 2022 | 71.0% | -4.1% |
| 2023 | 69.0% | -2.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 80.8% | 77.0% | 83.0% | 6 |
| 2000s | 81.6% | 72.0% | 86.0% | 10 |
| 2010s | 65.7% | 44.0% | 79.0% | 10 |
| 2020s | 72.8% | 69.0% | 77.0% | 4 |
Countries ranked near Chile
- 161 Bahamas 70.0% compare
- 161 Paraguay 70.0% compare
- 161 Sao Tome and Principe 70.0% compare
- 164 Mexico 69.0% compare
- 166 Colombia 68.0% compare
- 166 Equatorial Guinea 68.0% compare
- 166 Russian Federation 68.0% compare
More health data for Chile
- Un projection of annual infant deaths, annual growth rate -1.71 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4062 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,755 deaths per 1,000 people (2090)
- Number of infants who die before age 1 115 deaths (2100)
- Population ages 0-14, female, annual growth rate -2.01 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.0812 units per person (2025)
- Population ages 0-14, male, annual growth rate -1.99 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.0843 units per person (2025)
Frequently asked questions
- What is tuberculosis treatment success rate in Chile?
- Tuberculosis treatment success rate in Chile was 69.0% in 2023, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest tuberculosis treatment success rate recorded in Chile?
- The highest recorded value was 86.0% in 2002.
- What is the lowest tuberculosis treatment success rate recorded in Chile?
- The lowest recorded value was 44.0% in 2012.
- How does Chile rank for tuberculosis treatment success rate?
- Chile ranks 164th out of 206 countries with data for 2023.
- Is tuberculosis treatment success rate rising or falling in Chile?
- Over the last ten years it is up 46.8%. The long-run trend across the full record is falling.
- Where does this Chile data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Tuberculosis treatment success rate. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Treatment success rate among new and relapse cases.